Telenti A - Search Results

1

Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo.

Colombo S, Soranzo N, Rotger M, Sprenger R, Bleiber G, Furrer H, Buclin T, Goldstein D, Décosterd L, Telenti A; Swiss HIV Cohort Study. Colombo S, et al. Among authors: telenti a. Pharmacogenet Genomics. 2005 Sep;15(9):599-608. doi: 10.1097/01.fpc.0000172241.42546.d3. Pharmacogenet Genomics. 2005. PMID: 16041239

2

CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter gene.

Eap CB, Fellay J, Buclin T, Bleiber G, Golay KP, Brocard M, Baumann P, Telenti A. Eap CB, et al. Among authors: telenti a. Pharmacogenetics. 2004 Apr;14(4):255-60. doi: 10.1097/00008571-200404000-00005. Pharmacogenetics. 2004. PMID: 15083070

3

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.

Rotger M, Colombo S, Furrer H, Bleiber G, Buclin T, Lee BL, Keiser O, Biollaz J, Décosterd L, Telenti A; Swiss HIV Cohort Study. Rotger M, et al. Among authors: telenti a. Pharmacogenet Genomics. 2005 Jan;15(1):1-5. doi: 10.1097/01213011-200501000-00001. Pharmacogenet Genomics. 2005. PMID: 15864119

4

Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?

Colombo S, Telenti A, Buclin T, Furrer H, Lee BL, Biollaz J, Decosterd LA; Swiss HIV Cohort Study. Colombo S, et al. Among authors: telenti a. Ther Drug Monit. 2006 Jun;28(3):332-8. doi: 10.1097/01.ftd.0000211807.74192.62. Ther Drug Monit. 2006. PMID: 16778716

5

Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.

Colombo S, Buclin T, Décosterd LA, Telenti A, Furrer H, Lee BL, Biollaz J, Eap CB; Swiss HIV Cohort Study. Colombo S, et al. Among authors: telenti a. Clin Pharmacol Ther. 2006 Oct;80(4):307-18. doi: 10.1016/j.clpt.2006.06.006. Clin Pharmacol Ther. 2006. PMID: 17015049

6

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.

Arnedo M, Taffé P, Sahli R, Furrer H, Hirschel B, Elzi L, Weber R, Vernazza P, Bernasconi E, Darioli R, Bergmann S, Beckmann JS, Telenti A, Tarr PE; Swiss HIV Cohort Study. Arnedo M, et al. Among authors: telenti a. Pharmacogenet Genomics. 2007 Sep;17(9):755-64. doi: 10.1097/FPC.0b013e32814db8b7. Pharmacogenet Genomics. 2007. PMID: 17700364

7

Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7.

Rotger M, Saumoy M, Zhang K, Flepp M, Sahli R, Decosterd L, Telenti A; Swiss HIV Cohort Study. Rotger M, et al. Among authors: telenti a. Pharmacogenet Genomics. 2007 Oct;17(10):885-90. doi: 10.1097/FPC.0b013e3282ef5cd1. Pharmacogenet Genomics. 2007. PMID: 17885627

8

Promoter polymorphisms and allelic imbalance in ABCB1 expression.

Loeuillet C, Weale M, Deutsch S, Rotger M, Soranzo N, Wyniger J, Lettre G, Dupré Y, Thuillard D, Beckmann JS, Antonarakis SE, Goldstein DB, Telenti A. Loeuillet C, et al. Among authors: telenti a. Pharmacogenet Genomics. 2007 Nov;17(11):951-9. doi: 10.1097/FPC.0b013e3282eff934. Pharmacogenet Genomics. 2007. PMID: 18075465

9

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function.

di Iulio J, Fayet A, Arab-Alameddine M, Rotger M, Lubomirov R, Cavassini M, Furrer H, Günthard HF, Colombo S, Csajka C, Eap CB, Decosterd LA, Telenti A; Swiss HIV Cohort Study. di Iulio J, et al. Among authors: telenti a. Pharmacogenet Genomics. 2009 Apr;19(4):300-9. doi: 10.1097/FPC.0b013e328328d577. Pharmacogenet Genomics. 2009. PMID: 19238117

10

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.

Lubomirov R, di Iulio J, Fayet A, Colombo S, Martinez R, Marzolini C, Furrer H, Vernazza P, Calmy A, Cavassini M, Ledergerber B, Rentsch K, Descombes P, Buclin T, Decosterd LA, Csajka C, Telenti A; Swiss HIV Cohort Study. Lubomirov R, et al. Among authors: telenti a. Pharmacogenet Genomics. 2010 Apr;20(4):217-30. doi: 10.1097/FPC.0b013e328336eee4. Pharmacogenet Genomics. 2010. PMID: 20139798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters